Aliyan Pharmaceuticals Llp

Aliyan Pharmaceuticals Llp — pharma in Sanand, Gujarat, India. FY 2026 financials and compliance.
LLPIN ABA-3787 Incorporated 25 January 2022 ROC Ahmedabad HQ Sanand, Gujarat, India
Active Limited Liability Partnership pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Contribution obligation
₹10,000
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
None
Secured borrowings
Company age
4 yrs
Est. 2022
Last financials
Mar 2025
Balance sheet date

About Aliyan Pharmaceuticals Llp

Data last updated: 05 March 2026

Aliyan Pharmaceuticals Llp is a limited liability partnership company based in Sanand, Gujarat, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 25 January 2022.

Registered with ROC Ahmedabad under LLPIN ABA-3787.

Capital: a total obligation of contribution of ₹10,000. It is led by designated partners including Abbasali Mahammadali Balospura and Aabid Ali.

Accounts filed on 31 March 2025. Office: B 109 Kunj Estate Changodar, Sanand, Gujarat, India – 382213.

Company Details of Aliyan Pharmaceuticals Llp
LLPIN ABA-3787
Incorporation Date 25 January 2022
Total Obligation of Contribution ₹10,000
ROC Ahmedabad
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Abbasali Mahammadali Balospura Designated Partner Aabid Ali Designated Partner Ahemadabbas Gulamhaidar Balospura Designated Partner
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    B 109 Kunj Estate Changodar, Sanand, Gujarat, India – 382213
  • Industry
    Pharma, Drug Formulation & Development
Company report
Aliyan Pharmaceuticals Llp — full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Aliyan Pharmaceuticals Llp report

Financials, compliance, directors, charges, ownership and filings for Aliyan Pharmaceuticals Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Aliyan Pharmaceuticals Llp

Aliyan Pharmaceuticals Llp is currently managed by 3 designated partners, with 2 former designated partners having served the organization. The current Designated Partners play a crucial role in shaping the company's strategic direction and governance.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Abbasali Mahammadali Balospura
Also directs: Joinhub Global Exports Llp, Joinhub Pharma Llp, Pyxus Pharmaceuticals Private Limited and 1 more
Designated Partner 28 Oct 2024 1 Years 8 Months Current
Aabid Ali
Also directs: Joinhub Pharma Llp, Pyxus Pharmaceuticals Private Limited, Emed Healthtech Private Limited and 2 more
Designated Partner 02 Dec 2025 0 Years 7 Months Current
Ahemadabbas Gulamhaidar Balospura
Also directs: Joinhub Global Exports Llp, Joinhub Pharma Llp, Gutsalve Lifesciences Private Limited and 4 more
Designated Partner 02 Dec 2025 0 Years 7 Months Current
View all designated partners

Financials of Aliyan Pharmaceuticals Llp FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated — Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings Aliyan Pharmaceuticals Llp

Aliyan Pharmaceuticals Llp does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Aliyan Pharmaceuticals Llp

View historical data on people associated with Aliyan Pharmaceuticals Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Aliyan Pharmaceuticals Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Aliyan Pharmaceuticals Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Aliyan Pharmaceuticals Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Aliyan Pharmaceuticals Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay — Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Aliyan Pharmaceuticals Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Aliyan Pharmaceuticals Llp

MSME Payment Delays by Aliyan Pharmaceuticals Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Aliyan Pharmaceuticals Llp

Subsidiaries & Group Companies of Aliyan Pharmaceuticals Llp

See the full corporate group — holding company, subsidiaries, associates and joint ventures of Aliyan Pharmaceuticals Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Aliyan Pharmaceuticals Llp

MCA Filings & Documents of Aliyan Pharmaceuticals Llp

Download official documents filed with the Ministry of Corporate Affairs — from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Aliyan Pharmaceuticals Llp

Directors
02 Dec 2025
Aabid Ali was appointed as a Designated Partner on 02 Dec 2025 & has been associated with this company since 7 months 6 days.
Directors
02 Dec 2025
Ahemadabbas Gulamhaidar Balospura was appointed as a Designated Partner on 02 Dec 2025 & has been associated with this company since 7 months 6 days.
Activity
31 Mar 2025
Aliyan Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Aliyan Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Directors
28 Oct 2024
Abbasali Mahammadali Balospura was appointed as a Designated Partner on 28 Oct 2024 & has been associated with this company since 1 year 8 months.
Activity
25 Jan 2022
Aliyan Pharmaceuticals Llp was registered on 25 Jan 2022 with Roc Ahmedabad & aged 4 years 5 months as per MCA records.

Frequently Asked Questions about Aliyan Pharmaceuticals Llp

Aliyan Pharmaceuticals Llp is an active limited liability partnership in the pharma sector based in Sanand, Gujarat, India. It was incorporated on 25 January 2022 (4+ years old) and is registered under LLPIN ABA-3787.

The current designated partners of Aliyan Pharmaceuticals Llp are:

The primary industry of Aliyan Pharmaceuticals Llp is pharma. The LLP specifically operates in drug formulation and development. The LLP is currently active in this sector.

Aliyan Pharmaceuticals Llp can be reached at the registered office: B 109 Kunj Estate Changodar, Sanand, Gujarat, India – 382213.

The total obligation of contribution is ₹10,000.

The LLP has its registered office at B 109 Kunj Estate Changodar, Sanand, Gujarat, India – 382213.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding — sourced from MCA, SEBI and RBI filings.

Subscription plans available